tiprankstipranks
Trending News
More News >
Vaxil Bio Ltd (TSE:VXL)
:VXL
Canadian Market

Vaxil Bio (VXL) Income Statement

Compare
22 Followers

Vaxil Bio Income Statement

Last quarter (Q4 2024), Vaxil Bio's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Vaxil Bio's net income was C$-22.00K. See Vaxil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ -2.00KC$ -25.00KC$ -57.00K
Operating Expenses
C$ 196.00KC$ 254.00KC$ 584.00KC$ 986.00KC$ 1.35M
Depreciation and Amortization
C$ 0.00C$ 167.90KC$ 2.00KC$ 25.00KC$ 57.00K
EBITDA
C$ -178.00KC$ -254.00KC$ -582.00KC$ -961.00KC$ -1.29M
Operating Income
C$ -196.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.35M
Other Income/Expenses
C$ 18.00KC$ 0.00C$ 0.00C$ 0.00C$ -11.00K
Pretax Income
C$ -178.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.36M
Net Income
C$ -178.00KC$ -254.00C$ -584.00KC$ -986.00KC$ -1.37M
Per Share Metrics
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ -0.01C$ -0.01
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ -0.01C$ -0.01
Weighted Average Shares Outstanding
136.98M 137.00M 136.98M 136.10M 101.74M
Weighted Average Shares Outstanding (Diluted)
136.98M 136.98M 136.98M 136.10M 101.74M
Currency in CAD

Vaxil Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis